Erasca, Inc. (ERAS)
3.30
-0.04
(-1.20%)
USD |
NASDAQ |
Dec 09, 16:00
3.31
+0.01
(+0.30%)
Pre-Market: 09:13
Erasca EPS Diluted (Quarterly): -0.1079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ALX Oncology Holdings, Inc. | -0.4133 |
| Prelude Therapeutics, Inc. | -0.2591 |
| Atea Pharmaceuticals, Inc. | -0.5319 |
| Immuneering Corp. | -0.3772 |
| ProKidney Corp. | -0.122 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.61M |
| Total Expenses (Quarterly) | 30.61M |
| Enterprise Value | 696.14M |
| Earnings Yield | -13.66% |
| Normalized Earnings Yield | -12.95 |